期刊文献+

宫颈鳞状细胞癌组织核糖体结合蛋白1、E2F转录因子1的表达及其临床意义

Expression of ribosome-binding protein 1 and E2F transcription factor 1 in cervical squamous cell carcinoma and its clinical significance
原文传递
导出
摘要 目的探讨宫颈鳞状细胞癌(cervical squamous cell carcinoma,CSCC)组织中核糖体结合蛋白1(reticulum ribosome-binding protein 1,RRBP1)、E2F转录因子1(E2F transcription factor 1,E2F-1)的表达与临床价值。方法选取山西省肿瘤医院2017年7月至2018年1月收治的CSCC患者83例作为CSCC组,另选取同期于我院行宫颈活检的慢性宫颈炎患者80例作为对照组。采用免疫组化法检测两组病变组织中RRBP1、E2F-1表达情况,分析二者与CSCC患者临床病理特征的关系。绘制Kaplan-Meier曲线并采用Log-rank检验比较不同RRBP1、E2F-1表达患者术后3年的生存情况。多因素Cox回归分析CSCC患者预后的影响因素。结果CSCC组RRBP1、E2F-1阳性表达率分别为74.70%、54.22%,高于对照组的18.75%、13.75%,差异有统计学意义(P<0.05)。不同FIGO分期、分化程度、淋巴结转移、肿瘤大小、脉管浸润、人乳头瘤病毒感染情况的CSCC患者癌组织中RRBP1、E2F-1表达情况对比差异有统计学意义(P<0.05)。RRBP1阳性组总生存率低于RRBP1阴性组,且E2F-1阳性组无瘤生存率、总生存率低于E2F-1阴性组(P<0.05)。多因素Cox回归分析结果提示FIGO分期、分化程度、淋巴结转移、脉管浸润、HPV感染、RRBP1与E2F-1表达是CSCC患者预后的影响因素(P<0.05)。结论CSCC患者癌组织中RRBP1、E2F-1阳性表达率异常升高,二者阳性表达率升高会降低患者术后总生存率,是其预后的影响因素。 Objective To investigate the expression and clinical relationship of reticulum ribosome-binding protein 1(RRBP1) and E2 F transcription factor 1(E2 F-1) in cervical squamous cell carcinoma(CSCC) tissue value.Methods A total of 83 CSCC patients admitted to Shanxi Cancer Hospital from July 2017 to January 2018 were selected as the CSCC group, and 80 patients with chronic cervicitis who underwent cervical biopsy in our hospital during the same period were selected as the control group.Immunohistochemical method was used to detect the expressions of RRBP1 and E2 F-1 in the lesions of the two groups, and the relationship between the two and the clinicopathological characteristics of CSCC patients were analyzed.The Kaplan-Meier curve was drawn and the Log-rank test was used to compare the 3-year survival of patients with different RRBP1 and E2 F-1 expressions.Multivariate Cox regression analysis of prognostic factors of CSCC patients.Results The positive expression rates of RRBP1 and E2 F-1 in CSCC group were 74.70% and 54.22%,respectively, which were higher than 18.75% and 13.75% in control group(P<0.05).There were significant differences in the expression of RRBP1 and E2 F-1 in cancer tissues of CSCC patients with different FIGO stages, degrees of differentiation, lymph node metastasis, tumor size, vascular invasion, and human papillomavirus infection(P<0.05).The overall survival rate of the RRBP1 positive group was lower than that of the RRBP1 negative group, and the tumor-free survival rate and overall survival rate of the E2 F-1 positive group were lower than those of the E2 F-1 negative group(P<0.05).Multivariate Cox regression analysis showed that FIGO stage, degree of differentiation, lymph node metastasis, vascular invasion, HPV infection, RRBP1 and E2 F-1 expression were prognostic factors in CSCC patients(P<0.05).Conclusion The positive expression rates of RRBP1 and E2 F-1 in cancer tissues of CSCC patients are abnormally increased, and the increased positive expression rates of the two can reduce the overall survival rate of patients after surgery, and are the prognostic factors.
作者 史璟 武燕 孟红艳 常江 Shi Jing;Wu Yan;Meng Hongyan;Chang Jiang(Department of Gynecology,Shanxi Cancer Hospital,Taiyuan Shanxi 030013,P.R.China;Department of Pathalogy,Shanxi Cancer Hospital,Taiyuan Shanxi 030013,P.R.China)
出处 《中国计划生育和妇产科》 2022年第5期106-112,共7页 Chinese Journal of Family Planning & Gynecotokology
基金 山西省科技攻关项目计划(项目编号:20170415011-6)。
关键词 宫颈鳞状细胞癌 核糖体结合蛋白1 E2F转录因子1 预后 临床病理特征 cervical squamous cell carcinoma ribosome binding protein 1 E2F transcription factor 1 prognosis clinicopathological features
  • 相关文献

参考文献8

二级参考文献67

  • 1姜可伟,王杉,叶颖江,虞有智,杜如昱.胃癌组织中细胞周期蛋白D1和细胞周期蛋白质依赖激酶6的表达与预后的关系[J].中华普通外科杂志,2005,20(12):800-802. 被引量:10
  • 2宋娟,杨玉珍,陈艺丹.E2F1在胃癌中的表达及其与Survivin、P53的相关性[J].胃肠病学和肝病学杂志,2006,15(6):572-575. 被引量:4
  • 3Malumbres M,Barbacid M.Mammalian cyclin-dependent kinasee[J].Trends Biochem Sci,2005,30(11):630-641.
  • 4Cruz JC,Tsai LH.A Jekyll and Hyde kinaseroles for cdk5 in brain development and disease[J].Curr Opin Neurobiol,2004,14(3):390-394.
  • 5Lolli G,Johnson LN.CAK-Cyclin-dependent activating kinase:A key kinase in cell cycle control and a target for drugs[J]?Cell Cycle,2005,4(4):572-577.
  • 6Loyer P,TrembleyJH,KatonaR,et al.Role of CDK/cyclin complexes in transcription and RNA splicing[J].Cell Signal,2005,17(9):1033-1051.
  • 7Chen HH,Wang YC,Fan MJ.Identification and characterization of the CDK12/cyclin L1 complex involved in alternative splicing regulation[J].Mol Cell Biol,2006,26(7):2736-2745.
  • 8Rivadenertia DB,Mayhew CN,Thangavel C,et al.Proliferative suppression by CDK4-6 inhibition:Complex function of the retinoblastoma pathway in liver tissue and hepatoma cells[J].Gastroenterology,2010,138(5):1920-1930.
  • 9Nidhi S,Cynthia T,Prashant T,et al.Control of the p53-p21CIP1 axis by E2F1,E2F2,and E2F3 is essential for G1/S progression and cellular transformation[J].J Biol Chem,2006,281(47):36124-36131.
  • 10Shao Y,Qu Y,Dang S,et al.MiR-145 inhibits oral squamous cell carcinoma(OSCC)cell growth by targeting c-Myc and Cdk6[J].Cancer Cell Int,2013,13(1):51.

共引文献137

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部